GenMark Diagnostics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

GenMark Diagnostics (NASDAQ: GNMK) announced participation in two upcoming investor conferences. The management team will present at the Canaccord 40th Annual Growth Conference on August 12, 2020, at 3:00 PM ET, with a live webcast available. They will also engage in one-on-one meetings at the Needham Med Tech and Diagnostics Conference on August 17, 2020; however, no webcast will be provided for this event. GenMark specializes in multiplex molecular diagnostic solutions to enhance patient care and reduce healthcare costs.

CARLSBAD, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in two upcoming investor conferences.

GenMark’s management team is scheduled to present at the Canaccord 40^th Annual Growth Conference on Wednesday, August 12^th, 2020 at 3:00pm ET. Interested parties can access the live and archived webcast at ir.genmarkdx.com.

GenMark’s management team will also be participating in one-on-one meetings at the 5^th Annual Needham Med Tech and Diagnostics 1x1 Conference on Monday, August 17, 2020.  Due to the format of this event no webcast will be available.

About GenMark Diagnostics
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor^® detection technology, GenMark's eSensor XT-8^® and ePlex^® systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections.  For more information, visit www.genmarkdx.com.

Investor Relations Contact
Leigh Salvo
(415) 937-5404
ir@genmarkdx.com

FAQ

When will GenMark Diagnostics present at the Canaccord 40th Annual Growth Conference?

GenMark Diagnostics will present at the Canaccord 40th Annual Growth Conference on August 12, 2020, at 3:00 PM ET.

Will there be a webcast for the Needham Med Tech and Diagnostics Conference?

No, there will not be a webcast available for the one-on-one meetings at the Needham Med Tech and Diagnostics Conference on August 17, 2020.

What is the focus of GenMark Diagnostics' ePlex system?

The ePlex system by GenMark is designed to optimize laboratory efficiency and address various infectious disease testing needs.

What is GenMark Diagnostics' NASDAQ stock symbol?

GenMark Diagnostics is listed on NASDAQ under the stock symbol GNMK.

How does GenMark Diagnostics aim to improve patient care?

GenMark Diagnostics enhances patient care through multiplex molecular diagnostic solutions that improve quality metrics and reduce total healthcare costs.